Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Infectious Disease
•
Tuberculosis
•
Inflammatory eye disorders
•
Scleritis
•
Ophthalmology
•
General Infectious Disease
•
Primary Care
How do you approach treatment of tuberculous scleritis in pregnancy?
Related Questions
What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
How would you manage a patient with progressive/refractory molluscum contagiosum who is well controlled on methotrexate for seropositive rheumatoid arthritis?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
In a patient with a history of seropositive erosive RA who has undergone treatment for a periprosthetic joint infection and currently has an antibiotic spacer in place with clinical improvement, what is the appropriate timing and strategy for restarting DMARDs and/or biologic therapy to balance infection risk with RA disease control?
Do you recommend chronic oral suppressive antibiotics after initial intensive treatment of 6-8 weeks in patients with culture-negative prosthetic joint or bone infections with retained hardware?
Do you provide empiric doxycycline for Lyme Disease to asymptomatic patients after a tick bite who haven't developed Erythema migrans or are not sure it was an Ixodes tick?
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
Do you routinely offer suppressive antibiotics to patients with a prosthetic joint infection when surgery is delayed for months?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
